Academic History
Natalie Vokes, MD, is an Assistant Professor in Thoracic/Head and Neck Medical Oncology and in Genomic Medicine at the University of Texas MD Anderson Cancer Center, Houston, TX. Dr Vokes obtained her medical degree from Harvard Medical School, Boston, MA, before completing her residency in Internal Medicine at Brigham and Woman’s Hospital, Boston, MA, and a fellowship in Hematology & Oncology at Dana-Farber Cancer Institute, Boston, MA.
She is an active member of the Society for Immunotherapy of Cancer, the American Association for Cancer Research, the International Association for the Study of Lung Cancer (IASCL) and the American Society of Clinical Oncology. Dr Vokes also serves on IASLC’s WCLC Immunotherapy Committee and Career Development Committee.
Speaking on immunotherapy in non-small cell lung cancer
Dr Vokes’ research investigates the role of mutations in driving disease and resistance in non-small cell lung cancer, including EGFR, TP53, KEAP1 and STK11. She is interested in how resistance to immune and targeted therapies arises in order to identify new approaches to target resistant disease and to develop predictive biomarkers for immunotherapy response.
